Thursday, 15 October 2026European Markets
ExploreSearch
ViaNews EU
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· March 14, 2026

Energy Secretary Chris Wright says oil prices may fall — but past wars rattled market for months. How to prepare

View original at finance.yahoo.com
Energy Secretary Chris Wright says oil prices may fall — but past wars rattled market for months. How to prepare Moneywise and Yahoo Finance LLC may earn commission or revenue through links in the content below…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • One asset will surge 400% in a year

    60% confidence

  • Gold has frequently performed well during times of market volatility and geopolitical uncertainty

    60% confidence

  • Oil and gas prices may not last long at current spike levels, with a temporary period of elevated energy prices that will not be long

    60% confidence

  • Missing just the 10 best days in the market over 20 years can cut overall returns nearly in half

    60% confidence

  • Nearly 50% of Americans are making one big Social Security mistake

    60% confidence

  • Investors should be fearful when others are greedy and greedy when others are fearful

    60% confidence

  • The current oil price spike timeframe is weeks, not months, in the worst case

    60% confidence

  • Something concerning could be coming for U.S. stocks that raises alarm bells for retirees

    60% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Cluster: Late-Stage Readouts and Regulatory Milestones
October 2026 brings a dense run of Phase 3 wins (ALOFT-IPF, RESTORE-3), new data presentations (Roche, Bayer, Lilly, Vertex, Galderma) and regulatory steps (FDA acceptance of Roche's vamikibart BLA, Scholar Rock's EMA resubmission). The next big catalyst is the ivonescimab FDA PDUFA date on 2026-11-14. Obesity combination studies (REDEFINE 4, TOGETHER-PsO) and the 2027 Maritime-1 completion point to more catalysts ahead. QAIAx's speculative AI-linked trial claims (the QIII pilot, targeted for 2027) are an unrelated micro-cap sideshow with weak evidence, and have little in common with the large-cap pipeline news.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,377 source documents archived
Query this data → isubstrate.com
Energy Secretary Chris Wright says oil prices may fall — but past wars rattled market for months. How to prepare — Source | Via News | ViaNews EU